Tumor‑associated glucocorticoid inhibition by mifepristone reduces polymorphonuclear myeloid‑derived suppressor cells and promotes antitumor immunity in triple‑negative breast cancer‑bearing mice
Oncology Reports · 2026
DOI: 10.3892/or.2026.9065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2026. Verfasst von Masato Kobayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Reproduction, Nippon Veterinary and Life Science University, Musashino, Tokyo 180‑8602, Japan. Hauptthemen laut MEDLINE: Mifepristone, Myeloid-Derived Suppressor Cells, Triple Negative Breast Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Reproduction, Nippon Veterinary and Life Science University, Musashino, Tokyo 180‑8602, Japan.
Zitieren
APA
Kobayashi, M., Konno, C., Shimizu, A., Kobayashi, M., & Hori, T. (2026). Tumor‑associated glucocorticoid inhibition by mifepristone reduces polymorphonuclear myeloid‑derived suppressor cells and promotes antitumor immunity in triple‑negative breast cancer‑bearing mice. Oncology Reports. https://doi.org/10.3892/or.2026.9065
Vancouver
Kobayashi M, Konno C, Shimizu A, Kobayashi M, Hori T. Tumor‑associated glucocorticoid inhibition by mifepristone reduces polymorphonuclear myeloid‑derived suppressor cells and promotes antitumor immunity in triple‑negative breast cancer‑bearing mice. Oncology Reports. 2026. doi:10.3892/or.2026.9065
BibTeX
@article{Kobayashi2026,
author = {Kobayashi, Masato and Konno, Chisana and Shimizu, Ayato and Kobayashi, Masanori and Hori, Tatsuya},
title = {Tumor‑associated glucocorticoid inhibition by mifepristone reduces polymorphonuclear myeloid‑derived suppressor cells and promotes antitumor immunity in triple‑negative breast cancer‑bearing mice},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9065}
}
EUVIMED